GATIFLOXACIN 0.3%w/v IP

An ocular antibiotic drug that treats infections of the eye. (S Ramesh, 2010) Exerts a broader spectrum of antibacterial activity than older quinolones, such as ciprofloxacin. (Caroline M Perry 1, 2002) A safe and effective medicine for the treatment of acute bacterial corneal ulcers. (Prajna, et al., 2006) Provides complete healing of bacterial corneal ulcers than with ciprofloxacin 0.3%. (Prajna, et al., 2006) A good therapeutic agent for ocular use against a wide range of microorganisms. (Schultz, 2012) Exhibits a high bacterial clearance rate and stronger antibacterial activity. (Tang Hezhen, 2018) Effectively clears the pathogen with fast and strong effects. (Lan Gong, 2010) Demonstrates better action against gram-positive cocci as compared with ciprofloxacin for the treatment of bacterial keratitis. (Pragya Parmar 1, 2006) An effective medication against a broad spectrum of bacteria that cause ocular infections in humans. (Schultz, 2012) Displays stronger antibacterial activity with a broader antimicrobial spectrum than levofloxacin A preferred alternative to ciprofloxacin as the first-line monotherapy in bacterial keratitis. (Pragya Parmar, 2006)